Dolby Laboratories
$ 64.28
0.44%
25 Feb - close price
- Market Cap 6,141,299,000 USD
- Current Price $ 64.28
- High / Low $ 64.75 / 63.23
- Stock P/E 25.92
- Book Value 27.15
- EPS 2.48
- Next Earning Report -
- Dividend Per Share $1.38
- Dividend Yield 2.16 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.09 %
- 52 Week High 82.51
- 52 Week Low 59.81
About
Dolby Laboratories, Inc. creates imaging and audio technologies that transform entertainment and communications in the theater, home, work, and mobile devices. The company is headquartered in San Francisco, California.
Analyst Target Price
$81.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-01-29 | 2025-11-18 | 2025-07-31 | 2025-04-30 | 2025-01-30 | 2024-11-19 | 2024-08-07 | 2024-05-02 | 2024-02-01 | 2023-11-16 | 2023-08-03 | 2023-05-04 |
| Reported EPS | 1.06 | 0.99 | 0.48 | 1.34 | 1.14 | 0.81 | 0.71 | 1.27 | 1.01 | 0.65 | 0.55 | 1.26 |
| Estimated EPS | 1.15 | 0.7044 | 0.71 | 1.2667 | 0.9767 | 0.7 | 0.59 | 1.19 | 0.86 | 0.53 | 0.55 | 0.98 |
| Surprise | -0.09 | 0.2856 | -0.23 | 0.0733 | 0.1633 | 0.11 | 0.12 | 0.08 | 0.15 | 0.12 | 0 | 0.28 |
| Surprise Percentage | -7.8261% | 40.5451% | -32.3944% | 5.7867% | 16.7196% | 15.7143% | 20.339% | 6.7227% | 17.4419% | 22.6415% | 0% | 28.5714% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Feb 2026 | Dec 2025 | Aug 2025 | May 2025 | Feb 2025 | Dec 2024 | Aug 2024 | May 2024 | Feb 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-02-18 | 2025-12-10 | 2025-08-20 | 2025-05-21 | 2025-02-19 | 2024-12-10 | 2024-08-27 | 2024-05-22 | 2024-02-22 | 2023-12-05 |
| Amount | $0.36 | $0.36 | $0.33 | $0.33 | $0.33 | $0.33 | $0.3 | $0.3 | $0.3 | $0.3 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: DLB
2026-02-18 23:57:23
Shriram Revankar, Senior Vice President at Dolby Laboratories Inc. (NASDAQ:DLB), sold 3,000 shares of Class A Common Stock for a total of $198,420. This transaction leaves him with 83,218 shares, including restricted stock units. The sale follows Dolby Laboratories reporting strong financial results for the first quarter of 2026, with both EPS and revenue surpassing expectations.
2026-02-18 16:14:31
Shriram Revankar, SVP at Dolby Laboratories, Inc., sold 3,000 shares of Class A Common Stock for $198,420, leaving him with 83,218 shares. This sale follows strong Q1 2026 financial results for Dolby, which saw EPS and revenue surpass analyst expectations. The article highlights Dolby's robust performance, with both earnings and revenue beating projections.
2026-02-18 10:12:00
Shriram Revankar, SVP at Dolby Laboratories (NASDAQ:DLB), sold 3,000 shares of Class A Common Stock for $198,420 on February 17, 2026. Following the sale, Revankar now holds 83,218 shares. This transaction comes shortly after Dolby Laboratories reported strong Q1 2026 financial results, exceeding EPS and revenue forecasts.
2026-02-18 00:57:23
Ryan Nicholson, VP, CAO and Corp. Controller at Dolby Laboratories (NASDAQ:DLB), sold 2,667 shares of Class A Common Stock for over $177,000 and also exercised options for 2,667 shares. Despite a recent stock drop, Dolby shows strong financial health with an impressive gross profit margin and a 12-year dividend increase streak, alongside beating recent Q1 2026 EPS and revenue expectations.
2026-02-17 22:57:22
Ryan Nicholson, VP at Dolby Laboratories (NASDAQ:DLB), sold 2,667 shares for $177,022 and exercised options for the same number of shares. This occurred as Dolby's stock is down 22% over the past year, trading near its 52-week low. Despite the stock performance, the company reports strong financial health with an 87.86% gross profit margin, a 2.26% dividend yield, and recently exceeded Q1 2026 earnings and revenue expectations.
2026-02-17 06:12:00
Shriram Revankar, SVP at Dolby Laboratories Inc. (NASDAQ:DLB), sold 3,000 shares of Class A Common Stock for $198,420 on February 17, 2026. Following the sale, Revankar now holds 83,218 shares, including restricted stock units. This transaction occurred shortly after Dolby Laboratories reported strong first-quarter 2026 financial results, exceeding both EPS and revenue expectations.
